Adipogenic Transcriptional Regulation of Hepatic Stellate Cells

• Published in: The Journal of biological chemistry Vol. 280; no. 6; pp. 4959 - 4967
• Main Authors: She, Hongyun, Xiong, Shigang, Hazra, Saswati, Tsukamoto, Hidekazu
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 11.02.2005; American Society for Biochemistry and Molecular Biology
• Subjects: Adipocytes - metabolism; Animals; CCAAT-Enhancer-Binding Proteins - metabolism; Cell Differentiation; Culture Media - pharmacology; DNA Primers - chemistry; DNA-Binding Proteins - metabolism; Fatty Acids - metabolism; Fibrosis; Lipid Metabolism; Liver - cytology; Liver - metabolism; Liver - pathology; Models, Biological; Oxygen - metabolism; Phenotype; PPAR gamma - metabolism; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Time Factors; Transcription Factors - metabolism; Transcription, Genetic
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M410078200

Hepatic stellate cells (HSC) undergo transdifferentiation (activation) from lipid-storing pericytes to myofibroblastic cells to participate in liver fibrogenesis. Our recent work demonstrates that depletion of peroxisome proliferator-activated receptor γ (PPARγ) constitutes one of the key molecular events for HSC activation and that ectopic expression of this nuclear receptor achieves the phenotypic reversal of activated HSC to the quiescent cells. The present study extends these findings to test a novel hypothesis that adipogenic transcriptional regulation is required for the maintenance of HSC quiescence. Comparative analysis of quiescent and activated HSC in culture reveals higher expression of putative adipogenic transcription factors such as CCAAT/enhancer-binding protein (C/EBP) α, C/EBPβ, C/EBPδ, PPARγ, liver X receptor α, sterol regulatory element-binding protein 1c and of adipocyte-specific genes in the quiescent cells. Conversely, activated HSC have increased expression of PPARβ, a transcription factor known to promote fatty acid oxidation. A treatment of activated HSC with the adipocyte differentiation mixture (isobutylmethylxanthine, dexamethasone, and insulin) or ectopic expression of PPARγ or SREBP-1c in these cells, induces a panel of adipogenic transcription factors, reduces PPARβ, and causes the phenotypic reversal to quiescent HSC. These results support the importance of adipogenic transcriptional regulation in HSC quiescence and provide a new framework for identifying novel molecular targets for the treatment of liver cirrhosis.